Gorog thrombosis test: Analysis of factors influencing occlusive thrombus formation

Hiroko Nishida, Mitsuru Murata, Koichi Miyaki, Kazuyuki Omae, Kiyoaki Watanabe, Yasuo Ikeda

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We used the Gorog Thrombosis Test to analyze the factors influencing the occlusion time, which represents platelet activation and subsequent occlusive thrombus formation, in 132 healthy Japanese volunteers (116 men, 16 women; mean age, 45.0 ± 12.0 years). The Gorog Thrombosis Test was designed to evaluate platelet aggregation and thrombolytic activity under a high shear stress condition (175 dynes/cm2) in a native blood sample in vitro. The mean ± SD occlusion time was 154.8 ± 64.7 s (men, 153.4 ± 64.2 s and women, 165.4 ± 56.5 s). The occlusion time was inversely correlated with von Willebrand factor ristocetin cofactor activity (VWF:Rco) (r = -0.242, P = 0.0055) and von Willebrand factor antigen (r = -0.230, P = 0.0080). The mean occlusion time in the group with VWF:Rco of at least 170% (137 s) was significantly shorter than that in the group with VWF:Rco less than 170% (156 s, P < 0.05). Platelet counts, other coagulation markers and smoking showed no significant correlations with occlusion time. Red blood cells (r = -0.177, P = 0.0365), hemoglobin (r = -0.191, P = 0.0245) and hematocrit (r = -0.182, P = 0.0329) also showed inverse correlations with the occlusion time. This report is the first to clearly demonstrate the role of von Willebrand factor in the formation of occlusive thrombi in the Gorog Thrombosis Test.

Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalBlood Coagulation and Fibrinolysis
Volume17
Issue number3
DOIs
Publication statusPublished - 2006 Apr

Fingerprint

von Willebrand Factor
Statistical Factor Analysis
Thrombosis
Platelet Activation
Platelet Count
Platelet Aggregation
Hematocrit
Healthy Volunteers
Hemoglobins
Erythrocytes
Smoking

Keywords

  • Gorog Thrombosis Test
  • Hematocrit
  • Hemoglobin
  • Occlusion time
  • Red blood cells
  • Thrombus formation
  • Von Willebrand factor antigen
  • Von willebrand factor ristocetin cofactor activity

ASJC Scopus subject areas

  • Hematology

Cite this

Gorog thrombosis test : Analysis of factors influencing occlusive thrombus formation. / Nishida, Hiroko; Murata, Mitsuru; Miyaki, Koichi; Omae, Kazuyuki; Watanabe, Kiyoaki; Ikeda, Yasuo.

In: Blood Coagulation and Fibrinolysis, Vol. 17, No. 3, 04.2006, p. 203-207.

Research output: Contribution to journalArticle

Nishida, Hiroko ; Murata, Mitsuru ; Miyaki, Koichi ; Omae, Kazuyuki ; Watanabe, Kiyoaki ; Ikeda, Yasuo. / Gorog thrombosis test : Analysis of factors influencing occlusive thrombus formation. In: Blood Coagulation and Fibrinolysis. 2006 ; Vol. 17, No. 3. pp. 203-207.
@article{b72eead8da124b19822c84d6966f73c8,
title = "Gorog thrombosis test: Analysis of factors influencing occlusive thrombus formation",
abstract = "We used the Gorog Thrombosis Test to analyze the factors influencing the occlusion time, which represents platelet activation and subsequent occlusive thrombus formation, in 132 healthy Japanese volunteers (116 men, 16 women; mean age, 45.0 ± 12.0 years). The Gorog Thrombosis Test was designed to evaluate platelet aggregation and thrombolytic activity under a high shear stress condition (175 dynes/cm2) in a native blood sample in vitro. The mean ± SD occlusion time was 154.8 ± 64.7 s (men, 153.4 ± 64.2 s and women, 165.4 ± 56.5 s). The occlusion time was inversely correlated with von Willebrand factor ristocetin cofactor activity (VWF:Rco) (r = -0.242, P = 0.0055) and von Willebrand factor antigen (r = -0.230, P = 0.0080). The mean occlusion time in the group with VWF:Rco of at least 170{\%} (137 s) was significantly shorter than that in the group with VWF:Rco less than 170{\%} (156 s, P < 0.05). Platelet counts, other coagulation markers and smoking showed no significant correlations with occlusion time. Red blood cells (r = -0.177, P = 0.0365), hemoglobin (r = -0.191, P = 0.0245) and hematocrit (r = -0.182, P = 0.0329) also showed inverse correlations with the occlusion time. This report is the first to clearly demonstrate the role of von Willebrand factor in the formation of occlusive thrombi in the Gorog Thrombosis Test.",
keywords = "Gorog Thrombosis Test, Hematocrit, Hemoglobin, Occlusion time, Red blood cells, Thrombus formation, Von Willebrand factor antigen, Von willebrand factor ristocetin cofactor activity",
author = "Hiroko Nishida and Mitsuru Murata and Koichi Miyaki and Kazuyuki Omae and Kiyoaki Watanabe and Yasuo Ikeda",
year = "2006",
month = "4",
doi = "10.1007/s10577-006-1036-7",
language = "English",
volume = "17",
pages = "203--207",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gorog thrombosis test

T2 - Analysis of factors influencing occlusive thrombus formation

AU - Nishida, Hiroko

AU - Murata, Mitsuru

AU - Miyaki, Koichi

AU - Omae, Kazuyuki

AU - Watanabe, Kiyoaki

AU - Ikeda, Yasuo

PY - 2006/4

Y1 - 2006/4

N2 - We used the Gorog Thrombosis Test to analyze the factors influencing the occlusion time, which represents platelet activation and subsequent occlusive thrombus formation, in 132 healthy Japanese volunteers (116 men, 16 women; mean age, 45.0 ± 12.0 years). The Gorog Thrombosis Test was designed to evaluate platelet aggregation and thrombolytic activity under a high shear stress condition (175 dynes/cm2) in a native blood sample in vitro. The mean ± SD occlusion time was 154.8 ± 64.7 s (men, 153.4 ± 64.2 s and women, 165.4 ± 56.5 s). The occlusion time was inversely correlated with von Willebrand factor ristocetin cofactor activity (VWF:Rco) (r = -0.242, P = 0.0055) and von Willebrand factor antigen (r = -0.230, P = 0.0080). The mean occlusion time in the group with VWF:Rco of at least 170% (137 s) was significantly shorter than that in the group with VWF:Rco less than 170% (156 s, P < 0.05). Platelet counts, other coagulation markers and smoking showed no significant correlations with occlusion time. Red blood cells (r = -0.177, P = 0.0365), hemoglobin (r = -0.191, P = 0.0245) and hematocrit (r = -0.182, P = 0.0329) also showed inverse correlations with the occlusion time. This report is the first to clearly demonstrate the role of von Willebrand factor in the formation of occlusive thrombi in the Gorog Thrombosis Test.

AB - We used the Gorog Thrombosis Test to analyze the factors influencing the occlusion time, which represents platelet activation and subsequent occlusive thrombus formation, in 132 healthy Japanese volunteers (116 men, 16 women; mean age, 45.0 ± 12.0 years). The Gorog Thrombosis Test was designed to evaluate platelet aggregation and thrombolytic activity under a high shear stress condition (175 dynes/cm2) in a native blood sample in vitro. The mean ± SD occlusion time was 154.8 ± 64.7 s (men, 153.4 ± 64.2 s and women, 165.4 ± 56.5 s). The occlusion time was inversely correlated with von Willebrand factor ristocetin cofactor activity (VWF:Rco) (r = -0.242, P = 0.0055) and von Willebrand factor antigen (r = -0.230, P = 0.0080). The mean occlusion time in the group with VWF:Rco of at least 170% (137 s) was significantly shorter than that in the group with VWF:Rco less than 170% (156 s, P < 0.05). Platelet counts, other coagulation markers and smoking showed no significant correlations with occlusion time. Red blood cells (r = -0.177, P = 0.0365), hemoglobin (r = -0.191, P = 0.0245) and hematocrit (r = -0.182, P = 0.0329) also showed inverse correlations with the occlusion time. This report is the first to clearly demonstrate the role of von Willebrand factor in the formation of occlusive thrombi in the Gorog Thrombosis Test.

KW - Gorog Thrombosis Test

KW - Hematocrit

KW - Hemoglobin

KW - Occlusion time

KW - Red blood cells

KW - Thrombus formation

KW - Von Willebrand factor antigen

KW - Von willebrand factor ristocetin cofactor activity

UR - http://www.scopus.com/inward/record.url?scp=33645517506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645517506&partnerID=8YFLogxK

U2 - 10.1007/s10577-006-1036-7

DO - 10.1007/s10577-006-1036-7

M3 - Article

C2 - 16575258

AN - SCOPUS:33645517506

VL - 17

SP - 203

EP - 207

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 3

ER -